Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Age>=50 and <=69years (2)Day workers (3)Subjects who sleep at least five hours per day usually (4)Subjects who can take a test using personal computer (5)Subjects who have given written informed consent prior to start of study
Exclusion criteria
Exclusion criteria: (1)Subjects who have a history or signs of a neurodegenerative disorder or cerebrovascular disease or cardiovascular disease or thyroid disease (2)Subjects having a liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, autoimmune disease, allergy disease, mental disorder, cancer, diabetes, infection disease, or other diseases (3)Subjects who take a sleeping drug, antipsychotic drug, anti-anxiety drug, antidepressant, antidiabetic drug or antihyperlipidemic drug (4)BMI>=30 (5)Subjects who usually take a functional foods or supplements that affects results (6)Heavy drinker (7)Subjects who have donated over 200 mL of blood within the last one month prior to the current study or over 400 mL of blood within the last three months prior to the study (8)Subjects who have severe anemia (Hb <=7g/dL) (9)Subjects who have been to get sick by collecting venous blood (10)Subjects who have allergic reaction to control or test food (11)Subjects who can't eat served control or test food all (12)Subjects who are planned to participate in other clinical study during current study (13) Subjects who can't keep eating and exercise habits during study (14)Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood parameters at 60, 120, and 240 min after single ingestion of edible powder containing diets or control diet. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive function, subjective assessment, etc., after single ingestion of edible powder containing diets or control diet. | — |
Countries
Japan
Contacts
TES Holdings Co. Ltd Department of Development for Clinical Trials